Your session is about to expire
← Back to Search
Health Support Interventions for Blood Pressure Control
N/A
Waitlist Available
Led By Francesca Gany, MD, MS
Research Sponsored by Memorial Sloan Kettering Cancer Center
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 9 months
Awards & highlights
Study Summary
This trial is studying the best way to help truck drivers who have high blood pressure and are at risk for cancer. They will be given health screenings and consultations to help them maintain a healthy weight and increase cancer screenings.
Who is the study for?
This trial is for male taxi drivers over 19 years old in NYC with high blood pressure, who plan to stay in the city for at least 9 months. They must have a cell phone capable of receiving texts and speak English, Spanish, Bengali, Urdu, or French. Part-time drivers and those with cardiovascular diseases other than hypertension are excluded.Check my eligibility
What is being tested?
The study tests different follow-up methods after Health Fairs to manage high blood pressure and reduce cancer risk among taxi drivers. It compares usual health fair follow-ups with additional tech support like text messaging and home monitoring plus social network support.See study design
What are the potential side effects?
Since this trial focuses on technology-based interventions rather than medications, traditional side effects are not a concern. However, participants may experience stress or anxiety from constant health monitoring or technical issues with devices.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 9 months
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~9 months
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
decrease in blood pressure levels
Trial Design
3Treatment groups
Experimental Treatment
Group I: Health Fairs (HF)Experimental Treatment1 Intervention
Drivers will undergo U&C Health Fair follow-up either Regular or Urgent Follow-up: Timeline is determined by health status, with regular follow-up continuing for at least two weeks and urgent follow-up continuing for at least a month
Group II: HF +Tech + social network support (SNS).Experimental Treatment1 Intervention
Drivers will receive:
U&C HF follow-up, Mobile text messaging intervention w/ interactive 2- way messaging to encourage BP management for nine months and home BP monitoring equipment with instructions to self-monitor BP for nine months A social network support intervention in which selected family/peers encourage drivers to maintain healthy behaviors for nine months
Group III: HF + text messaging + home BP monitoringExperimental Treatment1 Intervention
Drivers will receive: U&C HF follow-up, Mobile text messaging intervention w/ interactive 2- way messaging to encourage BP management for nine months A home BP monitoring equipment with instructions to self-monitor BP for nine months
Find a Location
Who is running the clinical trial?
Memorial Sloan Kettering Cancer CenterLead Sponsor
1,940 Previous Clinical Trials
588,726 Total Patients Enrolled
Francesca Gany, MD, MSPrincipal InvestigatorMemorial Sloan Kettering Cancer Center
8 Previous Clinical Trials
2,989 Total Patients Enrolled
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- You can speak English, Spanish, Bengali, Urdu, or French.The study is only open to male participants.You have or had heart problems such as coronary artery disease, angina or aortic stenosis. High blood pressure is not included.
Research Study Groups:
This trial has the following groups:- Group 1: Health Fairs (HF)
- Group 2: HF + text messaging + home BP monitoring
- Group 3: HF +Tech + social network support (SNS).
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Share this study with friends
Copy Link
Messenger